VVX-005

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameVVX-005

Drug Alias NameVVX005VXX005

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Biological material > Viral vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulantsViral fusion proteins inhibitors

TargetsViral fusion proteins

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesViravaxx Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesViravaxx Ag

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A